antiandrogens/headache

Lyen an sove nan clipboard la

Chwazi kalite sòt

13 rezilta yo

[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The contraceptive pill has been a revolution of the last 40 years. In Italy, however, it is much less widely used than in other countries. Explanations for this phenomenon range from religious implications and customs to misinformation and word-of-mouth communication of negative experiences. The

Interventions for hirsutism (excluding laser and photoepilation therapy alone).

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Hirsutism occurs in 5% to 10% of women of reproductive age when there is excessive terminal hair growth in androgen-sensitive areas (male pattern). It is a distressing disorder with a major impact on quality of life. The most common cause is polycystic ovary syndrome. There are many

[Uncommon initial symptoms of metastasized carcinoma of the prostate].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Four patients, men aged 81, 65, 69 and 52 years, presented with painless lymphomas, pain in the lower back and legs, venous thrombosis in an arm, and headache, vomiting and other neurological complaints, respectively. They were found to have carcinoma of the prostate with metastases. After

Prostate cancer presenting as a solitary cerebellar metastasis. A case report and review of the literature.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We describe a case of a 70-year-old patient with sudden onset of gait ataxia, headache, dizziness and dysarthria. Magnetic resonance imaging revealed a solitary lesion in the left cerebellar hemisphere with strong and irregular enhancement of the contrast medium, surrounded by extensive edema.

A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Our purpose in this study was to determine the efficacy and toxicity of losoxantrone (DuP-941), an anthrapyrazole, in patients with metastatic hormone-refractory prostate cancer. Patients with metastatic prostate cancer progressing on androgen ablation therapy without demonstrable antiandrogen

Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Bicalutamide is an oral nonsteroidal antiandrogen drug used during hormone ablation therapy for prostate cancer. A new generic formulation of bicalutamide has been developed. OBJECTIVE This study was conducted to meet Korean and US regulatory requirements for the marketing of the generic

5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Various treatments have been attempted for female pattern hair loss (FPHL), including topical minoxidil, oral antiandrogen and finasteride. But, there is no consensus on the standard treatment options. Clinical efficacy of finasteride in treating FPHL is still in controversy, but there is

Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Preclinical data suggest that small quantities of estramustine phosphate are synergistic with taxanes and may be useful in the treatment of hormone-refractory prostate cancer. The current trial was designed to reduce the duration of exposure to estramustine phosphate, which carries with it the risk

Delayed pituitary apoplexy in patient with advanced prostate cancer treated with gonadotrophin-releasing hormone agonists.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Gonadotrophin-releasing hormone agonists (GnRHAs) are used in many clinical conditions, particularly prostate cancer. There have been a few case reports of apoplexy from a previously undiagnosed pituitary tumour, occurring within hours to days of initiation of GnRHA therapy. We report a case of

[Two cases of non-functional gonadotroph adenoma pituitary apoplexy following GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

We report here two cases of pituitary apoplexy or pseudoapoplexy revealing a gonadotroph adenoma. A 69-year-old man, who had just started antiandrogen treatment (Gn-RH agonist) for prostatic cancer, was admitted to neurosurgery emergency because of increasing headache and visual impairment. The

Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE We investigate the prostate specific antigen (PSA) response rate with nilutamide as a second line hormonal agent in patients with advanced prostate cancer in whom androgen ablation failed. METHODS From 1998 to 2001, 28 patients with hormone resistant prostate cancer were treated with

Cross-sex hormone administration changes pain in transsexual women and men.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Chronic pain is gender-related, since there is a clear predominance of one sex with respect to the other in most pain syndromes. Gonadal hormones are known to affect the occurrence and incidence of pain. Transsexuals receive cross-sex hormones to develop and maintain somatic characteristics of the

Androgen excess in women: experience with over 1000 consecutive patients.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The objective of the present study was to estimate the prevalence of the different pathological conditions causing clinically evident androgen excess and to document the degree of long-term success of suppressive and/or antiandrogen hormonal therapy in a large consecutive population of patients. All

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye